Merck KGaA secures CRISPR patents in Japan and Singapore

The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

UK firm successfully challenges ‘Vagisan’ TM in Singapore

28 February 2020 UK-based pharmaceutical manufacturer Comb International, owner of the ‘Vagisil’ trademark, has successfully challenged the ‘Vagisan’ trademark at the Intellectual Property Office Singapore.

Americas

Merck KGaA secures second US CRISPR patent

9 April 2020 Millipore Sigma, the US life sciences business of Merck KGaA, has secured a patent for its CRISPR-chrom technology, bringing its total number of CRISPR-related patents to 23.

Americas

Merck expands CRISPR patent portfolio

12 May 2020 Merck has added two US patents to its CRISPR-Cas9 patent portfolio, and is already seeking licensing and product development partners, the German company announced yesterday, May 11.

More on this story

Americas

Merck expands CRISPR patent portfolio

12 May 2020 Merck has added two US patents to its CRISPR-Cas9 patent portfolio, and is already seeking licensing and product development partners, the German company announced yesterday, May 11.

Americas

Merck KGaA secures second US CRISPR patent

9 April 2020 Millipore Sigma, the US life sciences business of Merck KGaA, has secured a patent for its CRISPR-chrom technology, bringing its total number of CRISPR-related patents to 23.

Big Pharma

UK firm successfully challenges ‘Vagisan’ TM in Singapore

More on this story

Americas

Merck expands CRISPR patent portfolio

12 May 2020 Merck has added two US patents to its CRISPR-Cas9 patent portfolio, and is already seeking licensing and product development partners, the German company announced yesterday, May 11.

Americas

Merck KGaA secures second US CRISPR patent

9 April 2020 Millipore Sigma, the US life sciences business of Merck KGaA, has secured a patent for its CRISPR-chrom technology, bringing its total number of CRISPR-related patents to 23.

Big Pharma

UK firm successfully challenges ‘Vagisan’ TM in Singapore